Value

Strategy – Development – Partnering

PMP’s relationships with partners in the fields of science, medicine, and business provide the wide breadth of experience needed to support product development and commercialization programs that are enabling personalized medicine. PMP offers clients full customization of the services provided by these partners, tailored to meet your company’s needs.

Coupled with its own expertise in the worlds of science, medicine and business, PMP’s direct experience with our partners helps us to define and negotiate mutually beneficial relationships among many companies that are either directly or peripherally involved with personalized medicine. We have partnerships with companies and important organizations in the fields of:

• Science development support by optimizing the application of biomarker, pharmacogenomic and molecular diagnostic testing during pharmaceutical discovery, development, and commercialization.
• Medicine development support by improving standards of care and adding value to treatment approaches through clinical implementation of biomarker, pharmacogenomic and molecular diagnostic testing.
• Business development support throughout the transaction continuum from opportunity identification through deal closure, including company formation and funding.

PMP believes that one of the greatest barriers to the realization of personalized medicine is the inability for any one company that focuses in one of these three sectors to keep up with the latest advances in the other sectors – advances that could propel the company farther, faster. For example, the pharmacogenomics company often is lacking in the ability to define and execute the business tactics that will maximize its success. PMP taps into its own areas of expertise, as well as those of partner firms, to become a catalyst in the worldwide delivery of personalized medicine.

Together, we can and will accelerate the adoption personalized medicine at the molecular level.